Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive (Q41156): Difference between revisions
From determinar.ia.br - Determine suas informações
Changed label, description and/or aliases in pt-br, en |
Changed an Item |
||
| Property / Canonical URI | |||
| Property / Canonical URI: https://id.who.int/icd/entity/605048789 / rank | |||
Normal rank | |||
Revision as of 07:13, 13 August 2026
MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation
| Language | Label | Description | Also known as |
|---|---|---|---|
| default for all languages | 8A41.1 |
||
| English | Neuromyelitis optica myelin oligodendrocyte glycoprotein antibody-positive |
MOG antibody associated spectrum disorders are inflammatory demyelinating diseases of the central nervous system with a predilection for optic nerve that include a subgroup of patients with bilateral optic neuritis (ON), longitudinally extensive (> 3 vertebral segments) myelitis (often recurrent) and rarely patients with an NMO like presentation. The clinical and immunopathological phenotype is under active investigation |
